Association between glucose-lowering drugs and circulating insulin antibodies induced by insulin therapy in patients with type 2 diabetes

Table 2 Logistics regression analysis for risk factors of insulin antibodies

	OR	95%CI	P value
Diabetes duration	1.019	1.001-1.037	0.042
Types of OHAs	0.875	0.771-0.991	0.036
ALT	0.996	0.992-1.000	0.053
Triglyceride	0.920	0.867-0.976	0.005
FBG	1.069	1.029-1.111	0.001
GAD-Ab	1.025	1.004-1.047	0.021
With cancer	0.533	0.310-0.917	0.023

OR: Odds ratio; OHAs: Oral hypoglycemic agents; ALT: Alanine transferase; FBG: Fasting blood glucose; LDL-c: Low density lipoprotein cholesterol; GAD-Ab: Glutamic acid decarboxylase antibody.